bluuebunny/crossref_metadata_2025_split huggingface dataset:
Predictors of Depressed Mood in Spouses of Women With Breast Cancer
Authors: Lewis Frances Marcus , Fletcher Kristin A. , Cochrane Barbara B. , Fann Jesse R. 
Published: March 2008

Purpose Depressed mood in spouses of women with breast cancer deleteriously affects their own and their wife's functioning and their marital communication. However, no study has examined why some spouses get depressed whereas others do not, particularly during the first months of diagnosis and treatment, a known difficult time for couples. The current study has two purposes: to test a predictive model of spouses’ depressed mood and to evaluate the model's accuracy in distinguishing between normal and clinically depressed spouses. Methods Data were obtained from standardized questionnaires completed by 206 spouses and 206 wives recently diagnosed with nonmetastatic breast cancer. Spouses’ depressed mood was measured by the Center for Epidemiological Studies–Depression Scale. A total of 19 variables were extracted from the literature for testing in the model, including psychological, social, demographic, and disease- and treatment-related variables. Results Spouses were more likely to be depressed if they were older, less well educated, more recently married, reported heightened fears over their wife's well-being, worried about their job performance, were more uncertain about their future, or were in less well-adjusted marriages. The model correctly classified 89.2% of spouses’ mood (χ2 = 79.1; P < .001). Conclusion Spouses of women with local or regional breast cancer need to be screened for depressed mood and triaged into supportive services to better assist them manage the threat of their wife's breast cancer.
Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib
Authors: Dirix Luc Yves , Ignacio Jorge , Nag Shona , Bapsy Poonamally , Gomez Henry , Raghunadharao Digumarti , Paridaens Robert , Jones Stephen , Falcon Silvia , Carpentieri Marina , Abbattista Antonello , Lobelle Jean-Pierre 
Published: March 2008

Purpose Preclinical data showed that the combination of exemestane and celecoxib has synergistic effects. Therefore, a study was undertaken to explore the efficacy and tolerability of this combination in postmenopausal patients with advanced, hormone-sensitive breast cancer. Patients and Methods A randomized phase II study was conducted in postmenopausal patients with hormone-sensitive breast cancer and measurable disease who had progressive disease after treatment with tamoxifen. Patients were randomly assigned to either exemestane 25 mg daily or the combination of exemestane 25 mg daily with celecoxib 400 mg twice daily. Response Evaluation Criteria in Solid Tumors Group criteria were used to determine antitumor efficacy. Primary end point was the rate of clinical benefit. Secondary end points were tolerability, objective response rate, time to progression (TTP), and duration of clinical benefit. A pharmacodynamic and a pharmacokinetic study were conducted in parallel. Results One hundred eleven patients (exemestane, n = 55; combination, n = 56) were enrolled in 2002. The demographic characteristics and prognostic factors were similar in both arms. In the assessable population, 24 of 51 patients in the combination arm and 24 of 49 patients in the exemestane arm achieved clinical benefit. TTP was similar in both groups. Duration of clinical benefit was longer in the combination group (median, 96.6 v 49.1 weeks). The addition of celecoxib did not change the tolerability profile of exemestane alone. Conclusion Similar rates of clinical benefit were achieved in both groups.
Understanding of Prognosis and Goals of Care Among Couples Whose Child Died of Cancer
Authors: Edwards Kelly E. , Neville Bridget A. , Cook Earl F. , Aldridge Sarah H. , Dussel Veronica , Wolfe Joanne 
Published: March 2008

Purpose Little is known about how couples care for the terminally ill child with cancer. We assessed both parents’ understanding of prognosis and treatment goals for children with cancer and explored whether sex mediates these views. We also investigated whether discordance within couples regarding treatment goals was related to parental perception of the child's end-of-life (EOL) experience. Methods We surveyed mothers and fathers of children who died of cancer and were cared for at Children's Hospital (Boston, MA) and the Dana-Farber Cancer Institute (Boston, MA) between 2000 and 2004. Our sample included 38 couples (response rate, 56%). Results Willingness to participate did not differ by sex. At diagnosis, fathers and mothers held a similar understanding of the child's prognosis, and 58% of couples agreed on the goal of cure. During the EOL period, a majority of fathers and mothers reported lessening suffering as the primary goal. However, within couples there was poor agreement about the primary goal of care (κ = 0.07). When parents did not agree on the primary goal of lessening suffering, both parents were more likely to report that the child suffered significantly from cancer-directed treatment (P = .03). Conclusion Though parent goals are often concurrent at diagnosis, they frequently differ during the EOL period. Parent disagreement about the goal of lessening suffering at the EOL appears to impact how parents describe their child's experience of suffering. Creating opportunities for parents to work through their goals together may lead to improvements in the child's EOL experience.
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
Authors: Smith Justin S. , Chang Edward F. , Lamborn Kathleen R. , Chang Susan M. , Prados Michael D. , Cha Soonmee , Tihan Tarik , VandenBerg Scott , McDermott Michael W. , Berger Mitchel S. 
Published: March 2008

Purpose The prognostic role of extent of resection (EOR) of low-grade gliomas (LGGs) is a major controversy. We designed a retrospective study to assess the influence of EOR on long-term outcomes of LGGs. Patients and Methods The study population (N = 216) included adults undergoing initial resection of hemispheric LGG. Region-of-interest analysis was performed to measure tumor volumes based on fluid-attenuated inversion-recovery (FLAIR) imaging. Results Median preoperative and postoperative tumor volumes and EOR were 36.6 cm3 (range, 0.7 to 246.1 cm3), 3.7 cm3 (range, 0 to 197.8 cm3) and 88.0% (range, 5% to 100%), respectively. There was no operative mortality. New postoperative deficits were noted in 36 patients (17%); however, all but four had complete recovery. There were 34 deaths (16%; median follow-up, 4.4 years). Progression and malignant progression were identified in 95 (44%) and 44 (20%) cases, respectively. Patients with at least 90% EOR had 5- and 8-year overall survival (OS) rates of 97% and 91%, respectively, whereas patients with less than 90% EOR had 5- and 8-year OS rates of 76% and 60%, respectively. After adjusting each measure of tumor burden for age, Karnofsky performance score (KPS), tumor location, and tumor subtype, OS was predicted by EOR (hazard ratio [HR] = 0.972; 95% CI, 0.960 to 0.983; P < .001), log preoperative tumor volume (HR = 4.442; 95% CI, 1.601 to 12.320; P = .004), and postoperative tumor volume (HR = 1.010; 95% CI, 1.001 to 1.019; P = .03), progression-free survival was predicted by log preoperative tumor volume (HR = 2.711; 95% CI, 1.590 to 4.623; P ≤ .001) and postoperative tumor volume (HR = 1.007; 95% CI, 1.001 to 1.014; P = .035), and malignant progression-free survival was predicted by EOR (HR = 0.983; 95% CI, 0.972 to 0.995; P = .005) and log preoperative tumor volume (HR = 3.826; 95% CI, 1.632 to 8.969; P = .002). Conclusion Improved outcome among adult patients with hemispheric LGG is predicted by greater EOR.
Effect of Race on the Outcome of Pediatric Patients With Hodgkin's Lymphoma
Authors: Metzger Monika L. , Castellino Sharon M. , Hudson Melissa M. , Rai Shesh N. , Kaste Sue C. , Krasin Matthew J. , Kun Larry E. , Pui Ching-Hon , Howard Scott C. 
Published: March 2008

Purpose Some cooperative groups have found a survival disadvantage in black children with various childhood cancers. We examine the effects of race on clinical outcomes among children with Hodgkin's lymphoma (HL) treated with contemporary therapy at a tertiary care children's hospital. Patients and Methods Retrospective analysis of 327 children and adolescents diagnosed with HL between 1990 and 2005. Patients were treated with risk-directed multimodal therapy regardless of race, ethnicity, or ability to pay. Event-free and overall survival rates were compared for black and white children. Clinical characteristics, socioeconomic factors, and biologic features were analyzed for prognosis of treatment failure. Results The 262 white and 65 black patients did not differ significantly in presenting features, clinical characteristics, or enrollment in a clinical trial. More black patients (71% v 45%) resided in poor counties (P < .001). While black and white children were equally likely to have progressive disease or early relapse, black children were 3.7 times (95% CI, 1.7 to 8.0) more likely to relapse 12 months or more after diagnosis. The 5-year event-free survival was 71% ± 6.1% (SE) for black and 84% ± 2.4% for white children (P = .01). However, the 5-year survival rate did not differ between white and black children (94.4% v 94.7%). While black race and low hemoglobin concentration were independent predictors of treatment failure, only low hemoglobin concentration independently predicted poor survival. Conclusion Black children with Hodgkin's lymphoma have lower event-free survival than white children, but both populations have the same 5-year overall survival.
The Body Image and Relationships Scale: Development and Validation of a Measure of Body Image in Female Breast Cancer Survivors
Authors: Hormes Julia M. , Lytle Leslie A. , Gross Cynthia R. , Ahmed Rehana L. , Troxel Andrea B. , Schmitz Kathryn H. 
Published: March 2008

Purpose A self-report measure of body image in female breast cancer survivors, the Body Image and Relationships Scale (BIRS), was developed to address attitudes about appearance, health, physical strength, sexuality, relationships, and social functioning following treatment. Methods The 32-item measure, generated by expert consensus and revised based on focus group feedback, was administered to 95 female breast cancer participants twice within 1 to 2 weeks. Test-retest reliability, internal consistency, and validity of the measure were assessed using standard-scale construction techniques. The structure of the proposed measure was evaluated using exploratory factor analysis. Associations of the resulting factors and other variables were assessed using extreme groups analyses. Results The BIRS had satisfactory test-retest reliability and internal consistency. Principal axis factoring revealed three factors: (1) health and strength, (2) social barriers, and (3) appearance and sexuality. Correlations of the subscales with standardized measures of related constructs were significant and in the anticipated directions. Extreme groups analyses suggested associations between less physical activity and more impairment on factors 1 and 3, premenopausal status at first diagnosis and more impairment on factor 2, and younger age at the time of survey administration and more impairment on factor 3. Conclusion The proposed scale demonstrated satisfactory reliability and internal consistency. Factor analysis revealed three subscales with coherent item content and differential associations with measures of activity level, menopause status, and age. Observed relationships with other measures support convergent and divergent validity. Results suggest that the proposed scale is useful for clinical and research applications.
Job Loss and Re-Employment of Cancer Patients in Korean Employees: A Nationwide Retrospective Cohort Study
Authors: Park Jae-Hyun , Park Eun-Cheol , Park Jong-Hyock , Kim Sung-Gyeong , Lee Sang-Yi 
Published: March 2008

Purpose The aim of this study was to investigate whether a diagnosis of cancer has an impact on the cancer patients’ job loss and re-employment and to identify the factors affecting job loss and re-employment during 6 years of follow-up of Korean employees with cancer. Patients and Methods All employees except for the self-employed in Korea who were diagnosed with cancer during the 2001 calendar year (n = 5,396) were identified as the first baseline patients and were followed every 3 months over 6 years to estimate the time taken to job loss. Patients who lost their job within the first year after a diagnosis of cancer (n = 1,398) were identified as the second baseline patients and were followed up over 5 years to estimate the time taken to re-employment using the National Health Insurance claims data. Patient demographic, socioeconomic, and clinical variables were investigated as factors that affected job loss and re-employment. Results Among the first baseline cancer patients, 47.0% lost their job, and among the second baseline patients, 30.5% were re-employed over 69 to 72 months of follow-up. Female sex, younger age and older age, company employee, lower income, blood cancer, and brain and CNS, lung, and liver cancer were significant predictors of early job loss or delayed re-employment. Conclusion The diagnosis of cancer affects cancer patients’ employment status differently according to different factors: sex, age, type of job, income, and cancer site. Efforts should be made to support re-employment and reduce unnecessary work cessation and disparity between different demographic and socioeconomic groups of cancer survivors.
Smectite-illite-muscovite transformations, quartz dissolution, and Silica release in shales
Authors: van de Kamp Peter C. 
Published: March 2008

AbstractQuantitative analysis of the smectite-to-illite and illite-to-muscovite transformations indicates that 17–28 wt.% SiO2 and 17–23 wt.% SiO2, respectively, are liberated during these reactions, assuming that Al is conserved. Dissolution of quartz silt in shales yields up to 6–9% SiO2 in the range up to 200°C and a further 10–15% SiO2 in the 200–500°C range. For muds altered to shales at 200°C, 14–20 wt.% silica is evolved. From 200 to 500°C, a further 18–28 wt.% silica is evolved. Additional small amounts of silica may be released in the alteration of feldspar to clay and by stylolitization of quartz silt. Thus, in the burial and temperature range of diagenesis into the epizone, major quantities of silica are released from clays and by quartz dissolution in shales. Within this range of alteration, concomitant decline of whole-rock Si/Al (SiO2/Al2O3) in the transformation of smectite to illite to muscovite suggests the liberated silica migrates from the source shale. As a result, the metamorphosed shales are more micaceous and less quartzose than their progenitor muds. In the diagenetic zone and anchizone, the evolved silica is probably a major source of quartz cement in sandstones. In the epizone, evolved silica is commonly present in quartz veins in the parent rocks. Fluid-inclusion temperatures in quartz overgrowths and fracture fillings in some sandstones suggest that some cements may have been derived from downdip basinal shales and pressure solution in sandstones.
Pyroxene weathering to smectite: Conventional and cryo-field emission scanning electron microscopy, Koua Bocca ultramafic complex, Ivory Coast
Authors: Velbel Michael A. , Barker William W. 
Published: March 2008

AbstractAir-dried and high-pressure frozen/freeze-etched samples of clinopyroxene and smectite in a saprolitized clinopyroxenite from Koua Bocca, Ivory Coast, West Africa, were compared to characterize textures developed during natural weathering of chain silicates. Comparison with air-dried material allowed evaluation of high-pressure cryofixation as a technique for preserving textures of hydrated clay minerals. Air-dried pyroxene surfaces appear very smooth. Small, flat lamellae, oriented parallel to the c axis, lend a distinct splintery appearance to pyroxene surfaces in fully hydrated samples. These lamellae often display a combination of straight (110) pyroxene edges and a crinkled border, suggestive of smectite. Narrow lenticular (110) open cleavages occur in both preparations and are not a pressurization artifact. Most often these openings contain no secondary minerals. Spaces between pyroxene denticles, lined with collapsed smectite in air-dried samples, are filled with thin packets of anhedral smectite crystallites oriented face to face when hydrated. Smectite microboxwork preserves original topotactic textures developed during isovolumetric pyroxene transformation, and smaller nanoporosity appears in hydrated cryofixed examples. Occasional regions of edge-to-face ‘house of cards’ texture also occur. Elimination of sample preparation artifacts induced by surface tension during air drying demonstrates that pores actually present during a hydration reaction-driven weathering episode are smaller and more numerous than would be inferred from examining air-dried materials.
Adjuvant activity of type I interferons
Authors: Tovey Michael G. , Lallemand Christophe , Thyphronitis George 
Published: March 2008

AbstractType I interferons (IFNs) produced primarily by plasmacytoid dendritic cells (pDCs) as part of the innate immune response to infectious agents induce the maturation of myeloid DCs and enhance antigen presentation. Type I IFNs also enhance apoptosis of virus-infected cells, stimulate cross priming and enhanced presentation of viral peptides. Type I IFNs are powerful polyclonal B-cell activators that induce a strong primary humoral immune response characterized by isotype switching and protection against virus challenge. Type I IFNs stimulate an IgG2a antibody response characteristic of Th1 immunity when ad-mixed with influenza virus vaccine and injected intramuscurarly (i.m.) or administered intranasally. The adjuvant activity of type I IFNs has been shown to involve direct effects of IFN on B-cells, effects on T-cells, as well as effects on antigen presentation. Oromucosal administration of type I IFNs concomitantly with i.m. injection of vaccine alone can also enhance the antibody response to influenza vaccination by enhancing trafficking of antigen-presenting cells towards the site of vaccination. Recombinant IFNs are potent adjuvants that may find application in both parenterally and mucosally administered vaccines.
Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
Authors: Herndler-Brandstetter Dietmar , Veel Ellen , Laschober Gerhard T. , Pfister Gerald , Brunner Stefan , Walcher Susanne , Parson Walther , Lepperdinger Günter , Grubeck-Loebenstein Beatrix 
Published: March 2008

Abstract
The age-related decline in immune system functions is responsible for the increased prevalence of infectious diseases and the low efficacy of vaccination in elderly individuals. In particular, the number of peripheral naive T-cells declines throughout life and they exhibit severe functional defects at advanced age. However, we have recently identified a non-regulatory CD8+CD45RO+CD25+ T-cell subset that occurs in a subgroup of healthy elderly individuals, who still exhibit an intact humoral immune response following influenza vaccination. Here, we demonstrate that CD8+CD45RO+CD25+ T-cells share phenotypic and functional characteristics with naive CD8+CD45RA+CD28+ T-cells from young individuals, despite their expression of CD45RO. CD8+CD45RO+CD25+ T-cells also have long telomeres and upon antigenic challenge, they efficiently expand in vitro and differentiate into functional effector cells. The expanded population also maintains a diverse T-cell receptor repertoire. In conclusion, CD8+CD45RO+CD25+ T-cells from elderly individuals compensate for the loss of functional naive T-cells and may therefore be used as a marker of immunological competence in old age.
Novel strategies to identify biomarkers in tuberculosis
Authors: Jacobsen Marc , Mattow Jens , Repsilber Dirk , Kaufmann Stefan H.E. 
Published: March 2008

AbstractThe more we learn about the immune response against tuberculosis (TB) and particularly about the features which distinguish protective immunity, disease susceptibility and pathology, the better we can define biomarkers which correlate with these different stages of infection. The most widely used biomarker in TB, which without a doubt is an important component of protective immunity, is IFNγ secreted by antigen-specific CD4 T-cells. However, the complexity of the immune response against TB makes it more than likely that additional biomarkers are required for a reliable correlate of protection. As a corollary, we assume that a set of biomarkers will be required, termed a biosignature.
Inhibition of bacterial oxidases by formamide and analogs
Authors: Gupta Sayan , Mazumdar Shyamalava 
Published: March 2008

Abstract
The enzymatic activity of Paracoccus denitrificans cytochrome c oxidase (COX) and Escherichia coli cytochrome b
o ubiquinol oxidase (QOX) was determined in the presence of formamide, N,N-dimethyl formamide and N,N-dimethyl acetamide. Formamide was found to inhibit the enzyme activity of the oxidases most significantly, whereas the other two compounds inhibited the activity to a lesser extent. The effects of formamide and analogs on enzyme activity were very similar for COX and QOX, indicating that the mechanism of inhibition might be the same for both of these oxidases. The inhibition kinetics followed a non-competitive mechanism. Studies using proteoliposomes of COX and QOX containing the electron entry site of the enzyme directed towards the outside of the vesicles showed that the effect of inhibition by formamide was higher when the inhibitor was present on the outside of the proteoliposome compared to when it was present only in the aqueous core. This indicates that inhibition of enzyme activity by formamide possibly predominantly involves blocking of the water exit pathway in the oxidases.
Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
Authors: Thimme Robert , Neumann-Haefelin Christoph , Boettler Tobias , Blum Hubert E. 
Published: March 2008

AbstractHepatitis C virus (HCV) causes chronic infection in approximately two-thirds of cases, leading to chronic hepatitis, liver cirrhosis, liver disease, liver failure, and hepatocellular carcinoma in a substantial proportion of the 170 million HCV-infected individuals worldwide. It is generally accepted that the cellular immune response plays the most important role in determining the outcome of HCV infection. First, vigorous, multispecific and sustained CD4+and CD8+T-cell responses are associated with viral clearance. Second, depletion studies in chimpanzees, the only other host of HCV besides humans, have shown that both CD4+and CD8+T-cells are required for virus elimination. Third, the host's human leukocyte antigen alleles, which restrict the repertoire of CD4+and CD8+T-cell responses, influence the outcome of infection. Of note, protective immunity has been demonstrated in population-based studies, as well as in experimentally infected chimpanzees. Thus, a detailed understanding of the mechanisms contributing to the failure of the antiviral immune response should allow successful development of prophylactic and therapeutic vaccination strategies.